Harnessing IDO inhibitors to optimize cancer immunotherapy. - Rab SO; Jaafar HK; Jabir MS; Malathi H; Devi S; Pramanik A; Al-Hetty HRAK; Alnajar MJ; Jawad SF; Mustafa YF (Naunyn-Schmiedeberg's archives of pharmacology, 2025)